Science Explorer Interactive view Map
Company · Göttingen · Germany

Juno Therapeutics (Germany)

junotherapeutics.comROR OpenAlex
Research works
39
▲ 20% vs 2013–17
Citations
1.2k
30.1 per fractional work
Top-10% rate
7.7%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Juno Therapeutics (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.88× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.68× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.79× its world share, 0 worksImmunology and Micro…Chemistry: 2.19× its world share, 0 worksChemistryComputer Science: 0.22× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.87× its world share, 0 worksEarth and Planetary …Engineering: 1.17× its world share, 2 worksEngineeringEnvironmental Science: 1.17× its world share, 1 worksEnvironmental ScienceMedicine: 2.35× its world share, 4 worksMedicineSocial Sciences: 0.14× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.8×. Every wedge is a field page.

Who are the top researchers at Juno Therapeutics (Germany)?

Ranked on the composite score, Adnan Deronic lead among researchers whose main affiliation is Juno Therapeutics (Germany).

  1. 1 Adnan Deronic Germany · #1,605,165 worldwide 0 citations · 24 works
All ranked researchers at Juno Therapeutics (Germany)

Which keywords describe research at Juno Therapeutics (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Immunity and Natural Killer Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Cancer Immunotherapy5▲ 91×2 topics
  2. Immunotherapy4▲ 18×4 topics
  3. Lymphoma4▲ 68×2 topics
  4. Tumor Regression4▲ 118×2 topics
  5. CAR T Cells4▲ 224×1 topic
  6. Chimeric Antigen Receptor4▲ 224×1 topic
  7. Epidemiology2▲ 1.17×9 topics
  8. Immunity2▲ 14×2 topics
  9. NK Cell Recognition2▲ 44×1 topic
  10. Natural Killer Cells2▲ 44×1 topic
  11. Cell-Free DNA2▲ 46×2 topics
  12. Glycosylation1▲ 17×2 topics
  13. Prognostic Factors1▲ 8.1×6 topics
  14. Antigen Presentation1▲ 30×1 topic
  15. Assisted Reproductive Technology1▲ 44×2 topics
  16. Dendritic Cells1▲ 26×1 topic
  17. Monoclonal Antibodies1▲ 19×2 topics
  18. Public Health1▲ 2.0×2 topics
  19. Sustainability1▲ 1.61×6 topics
  20. Tumor Microenvironment1▲ 8.3×3 topics
  21. Disaster Response1▲ 33×1 topic
  22. Inflammation1◆ 1.09×2 topics
  23. Triage1▲ 66×1 topic

Which research topics does Juno Therapeutics (Germany) publish most on?

By volume in 2022–2025: Prenatal Screening and Diagnostics, Assisted Reproductive Technology and Twin Pregnancy, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.

Prenatal Screening and Diagnostics: 1 fractional worksAssisted Reproductive Technology and Twin Pregnancy: 1 fractional worksCAR-T cell therapy research: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksClick Chemistry and Applications: 0 fractional worksMicrogrid Control and Optimization: 0 fractional worksOptimal Power Flow Distr…0Optimal Power Flow Distribution: 0 fractional worksAdvanced Battery Technologies Research: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional works
Pediatrics, Perinatology and Child HealthOncologyRadiology, Nuclear Medicine and ImagingOrganic Chemistry5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 1 works
  2. 2 Assisted Reproductive Technology and Twin Pregnancy Pediatrics, Perinatology and Child Health 1 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Click Chemistry and Applications Organic Chemistry 0 works
  6. 6 Microgrid Control and Optimization Control and Systems Engineering 0 works
  7. 7 Optimal Power Flow Distribution Electrical and Electronic Engineering 0 works
  8. 8 Advanced Battery Technologies Research Automotive Engineering 0 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  10. 10 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.2%not open51.8%

World: 28% of research is openly available.

with international co-authors63.5%domestic only36.5%

World: 19% is written across borders.

How has Juno Therapeutics (Germany)'s research output changed?

Output in 2018–2022 was 20% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Göttingen

All research institutions in Göttingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.